EXOC7
Exocyst complex component 7
Also known as: BLOM4, EXO70, Exo70p, EXOC7_HUMAN, KIAA1067, YJL085W
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UPT5
- Gene
- EXOC7
- Ensembl
- ENSG00000182473
- Chromosome
- 17
- Canonical length
- 735 aa
- Protein class
- Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters
- Subcellular location
- Vesicles,Plasma membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a component of the exocyst complex. The exocyst complex plays a critical role in vesicular trafficking and the secretory pathway by targeting post-Golgi vesicles to the plasma membrane. The encoded protein is required for assembly of the exocyst complex and docking of the complex to the plasma membrane. The encoded protein may also play a role in pre-mRNA splicing through interactions with pre-mRNA-processing factor 19. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 4. [provided by RefSeq, Nov 2011]
Canonical amino-acid sequenceUniProt
735 residues, UniProt reviewed canonical sequence.
>Q9UPT5|EXOC7
1 MIPPQEASAR RREIEDKLKQ EEETLSFIRD SLEKSDQLTK NMVSILSSFE SRLMKLENSI
61 IPVHKQTENL QRLQENVEKT LSCLDHVISY YHVASDTEKI IREGPTGRLE EYLGSMAKIQ
121 KAVEYFQDNS PDSPELNKVK LLFERGKEAL ESEFRSLMTR HSKVVSPVLI LDLISGDDDL
181 EAQEDVTLEH LPESVLQDVI RISRWLVEYG RNQDFMNVYY QIRSSQLDRS IKGLKEHFHK
241 SSSSSGVPYS PAIPNKRKDT PTKKPVKRPG TIRKAQNLLK QYSQHGLDGK KGGSNLIPLE
301 GLLPCTPRGG LPGPWINAAC VCAADISPGH EHDFRVKHLS EALNDKHGPL AGRDDMLDVE
361 TDAYIHCVSA FVKLAQSEYQ LLADIIPEHH QKKTFDSLIQ DALDGLMLEG ENIVSAARKA
421 IVRHDFSTVL TVFPILRHLK QTKPEFDQVL QGTAASTKNK LPGLITSMET IGAKALEDFA
481 DNIKNDPDKE YNMPKDGTVH ELTSNAILFL QQLLDFQETA GAMLASQETS SSATSYSSEF
541 SKRLLSTYIC KVLGNLQLNL LSKSKVYEDP ALSAIFLHNN YNYILKSLEK SELIQLVAVT
601 QKTAERSYRE HIEQQIQTYQ RSWLKVTDYI AEKNLPVFQP GVKLRDKERQ IIKERFKGFN
661 DGLEELCKIQ KAWAIPDTEQ RDRIRQAQKT IVKETYGAFL QKFGSVPFTK NPEKYIKYGV
721 EQVGDMIDRL FDTSALocalizationUniProt · AlphaFold · HPA
Whether an antibody against EXOC7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 58 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 58 nTPM
- bone marrow: 50 nTPM
- fallopian tube: 49 nTPM
- esophagus: 49 nTPM
- salivary gland: 48 nTPM
- prostate: 45 nTPM
Single-cell type
- esophageal apical cells: 180 nCPM
- tuft cells: 138 nCPM
- pituitary stem cells: 82 nCPM
- syncytiotrophoblasts: 82 nCPM
- late spermatids: 80 nCPM
- fallopian tube ciliated cells: 79 nCPM
Immune cell
- non-classical monocyte: 80 nTPM
- eosinophil: 66 nTPM
- intermediate monocyte: 57 nTPM
- basophil: 55 nTPM
- neutrophil: 46 nTPM
- total PBMC: 45 nTPM
Brain region
- pons: 70 nTPM
- hippocampal formation: 69 nTPM
- cerebral cortex: 68 nTPM
- hypothalamus: 68 nTPM
- basal ganglia: 67 nTPM
- medulla oblongata: 67 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EXOC7.
Disease | AllUniProt
Conditions EXOC7 is implicated in, by any mechanism.
- Neurodevelopmental disorder with seizures and brain atrophy (NEDSEBA) MIM:619072
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 159 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with seizures and brain atrophy
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.88
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- exocytosis
- membrane fission
- mitotic cytokinesis
- positive regulation of mitotic cytokinetic process
- protein transmembrane transport
- regulation of entry of bacterium into host cell
- regulation of macroautophagy
- vesicle docking involved in exocytosis
- vesicle tethering involved in exocytosis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cullin repeat-like-containing domain superfamily
- Exocyst complex component Exo70
- Exocyst complex subunit Exo70, C-terminal
- Exo70 exocyst complex subunit C-terminal
- Exocyst complex component Exo70 N-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EXOC7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EXOC7 as an antibody target. Whether an autoantibody or antibody against EXOC7 could matter depends on whether native EXOC7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EXOC7 is annotated at the cell surface, where native EXOC7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label EXOC7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...